MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Effect of CUE1+ Device on Motor and Non-Motor Symptoms in Parkinson’s: A Pilot Randomised Controlled Trial.

    V. Azoidou, K. Rowsell, E. Camboe, K. Dey, A. Zirra, C. Quah, T. Boyle, C. Budu, D. Gallagher, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: To assess the effect CUE1+ device on motor and non-motor symptoms in people with Parkinson’s (PwP). Background: Current treatments for PwP often fail to…
  • 2025 International Congress

    The IMPACT study: protocol of a randomised controlled single-blind trial evaluating efficacy and cost-effectiveness of telenursing in atypical parkinsonism

    R. Cilia, V. Leta, F. Colucci, A. Suppa, F. Valentino, C. Terranova, C. Leuzzi, J. Cordasco, G. Fusi, S. Floridia, F. de Giorgi, R. Telese, A. Braccia, A. Zampogna, G. Pinola, M. Patera, G. Belluscio, S. Crivellari, E. Antoniazzi, S. Cascino, A. Giaco, A. Masaracchio, G. Moreschi, M. Catotti, R. Eleopra (Milan, Italy)

    Objective: To present the protocol of a study evaluating the efficacy and cost-effectiveness of a 12-month integrated program aimed at improving healthcare delivery and coordinated…
  • 2025 International Congress

    Neurologic Music Therapy and Non-Invasive Brain Stimulation for Upper Extremity Performance in Patients with Corticobasal Syndrome

    K. Kang, I. Sterner, S. Bakhshi, C. Bedell, A. Pantelyat (Baltimore, USA)

    Objective: To explore the effects of Neurologic Music Therapy (NMT) with or without non-invasive brain stimulation on upper limb performance in patients with corticobasal syndrome…
  • 2025 International Congress

    Dopa-Responsive Parkinsonism Secondary to Tauopathy: Clinical, Pathological, and Genetic Study

    S. Giri Ravindran, B. Daud Shah, E. Noyes, V. Zherebitskiy, A. Rajput, M. Farrer, A. Rajput (Saskatoon, Canada)

    Objective: To report on the clinical, pathological, and genetic findings of four cases of levodopa-responsive parkinsonism with long survival and tauopathy. Background: The most common…
  • 2025 International Congress

    Utilizing the Global Parkinson’s Genetics Program (GP2) to develop a precision medicine recruitment protocol

    K. Atterling Brolin, YY. Beh, P. Saffie Awad, J. Aviles, A. Pajo, E. Navarro-Jones, C. Klein, I. F. Mata, K. Paquette, H. Iwaki, L. Jones, H. Leonard, N. Okubadejo, C. Blauwendraat, L. Screven, A. Noyce, M. Toffoli, AH. Tan, H. Morris, M. Nalls (Lund, Sweden)

    Objective: Can the Global Parkinson’s Genetics Program (GP2, http://gp2.org/) leverage its rich data and connectivity to address the growing issue of identifying individuals that can…
  • 2025 International Congress

    Noradrenaline treatment of apathy and impulsivity in participants with Progressive Supranuclear Palsy syndromes (NORAPS)

    R. Durcan, H. Paula, D. Street, A. Murley, S. Jones, A. Church, C. Kobylecki, V. Marshall, C. Antoniades, B. Ghosh, J. Rowe (Cambridge, United Kingdom)

    Objective: The NORAPS phase II study (ISRCTN99462035) investigates the safety, tolerability and efficacy of atomoxetine in Progressive Supranuclear Palsy (PSP). Background: PSP is a neurodegenerative…
  • 2024 International Congress

    Intensive Neurophysiological Rehabilitation System As a New Approach for Treatment of ASD Children

    T. Voloshyn (lviv, Ukraine)

    Objective: Rehabilitation of ASD children is the issue of the day as it's attributed to constantly increasing quantity of autistic children. Background: Existing rehabilitation approaches…
  • 2024 International Congress

    MOVE-PD: Mapping the Correlation of Sedentary behavior with Motor Symptoms in Parkinson’s Disease

    J. Frederiksen, TH. Thomsen, B. Biering- Sørensen, U. Dalgas, M. Langeskov-Christensen (Glostrup, Denmark)

    Objective: Mapping the correlation between sedentary behavior (SB) and Parkinsons (PD) specific motor symptoms, measured on objective data from wearables. Background: People with Parkinson's (Pwp)…
  • 2024 International Congress

    Functional Changes Occuring During 10-Week Parkinson’s Disease Group Fitness Classes and Subsequent 8-Week Break

    T. Luszeck, C. Young, R. Purcell, K. Hopkinson, M. Timpson (Provo, USA)

    Objective: To examine the effects of participation in a 10-week Community-Based Group Exercise Class, followed by an 8-week break on the functional abilities of individuals…
  • 2024 International Congress

    Hand and Arm Function in Persons with De Novo Parkinson’s Disease

    B. Lindholm, LB. Dahlin, CH. Brogårdh, E. Franzen (Malmö, Sweden)

    Objective: To evaluate hand and arm function and its association with motor symptoms as well as activities of daily living (ADL) in de novo Parkinson's…
  • « Previous Page
  • 1
  • …
  • 386
  • 387
  • 388
  • 389
  • 390
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley